Trial intelligence / Profile preview

Ticagrelor vs Clopidogrel for Reperfusion in AMI

NCT02233790Phase 4Unknown

Sponsor
First Hospital of China Medical University
Start
Dec 2014
Primary completion
Sep 2016
Countries
1
01

Overview

A Phase 4 trial of ticagrelor in myocardial infarction (MI), no-reflow phenomenon, sponsored by First Hospital of China Medical University. Status: unknown.

02

Drugs

ticagrelor
03

Conditions

myocardial infarction (MI)no-reflow phenomenon

Beyond the preview

Go deeper on NCT02233790.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02233790.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call